Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riboflavin for Acute Ischemic Stroke
NCT02446977Phase 2Completed
- Start
- Mar 2015
- Primary completion
- Dec 2015
- Countries
- 1
01
Overview
A Phase 2 trial of riboflavin in ischemic stroke. Started Mar 2015; status: completed.
02
Drugs
riboflavin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02446977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02446977.